Asia Pacific Diabetic Neuropathy Treatment Market Size, Share & Trends Analysis Report By Distribution Channel, By Drug Class, By Disorder Type, By Country and Growth Forecast, 2024 - 2031

The Asia Pacific Diabetic Neuropathy Treatment Market would witness market growth of 8.2% CAGR during the forecast period (2024-2031).

The China market dominated the Asia Pacific Diabetic Neuropathy Treatment Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $522.6 million by 2031. The Japan market is registering a CAGR of 7.5% during (2024 - 2031). Additionally, The India market would showcase a CAGR of 8.8% during (2024 - 2031).

Another factor contributing to the growth of the diabetic neuropathy treatment market is the expanding range of treatment options available. Traditionally, the management of diabetic neuropathy has focused on controlling blood sugar levels and relieving symptoms such as pain and discomfort.

Moreover, these approaches remain important, there has been a shift towards a more comprehensive treatment strategy that addresses the underlying causes of nerve damage and aims to prevent or reverse the condition's progression.

India is experiencing a significant increase in diabetes prevalence, driven by factors such as urbanization, sedentary lifestyles, and dietary changes. Based on data from the National Library of Medicine, the estimated number of individuals with diabetes in India in 2019 was 77 million, and this figure is projected to surpass 134 million by 2045. It is projected that approximately 592 million individuals will perish from diabetes by 2035.

Free Valuable Insights: The Global Diabetic Neuropathy Treatment Market is Predict to reach USD 7.4 Billion by 2031, at a CAGR of 7.3%

Based on Distribution Channel, the market is segmented into Hospitals Pharmacies, Retail Pharmacies and Others. Based on Drug Class, the market is segmented into Non-Steroidal Anti-inflammatory Drugs (NSAIDs), Antidepressants, Opioid, Capsaicin and Others. Based on Disorder Type, the market is segmented into Peripheral Neuropathy, Autonomic Neuropathy, Proximal Neuropathy and Focal Neuropathy.Based on countries, the market is segmented into China, Japan, India, South Korea, Australia, Malaysia, and Rest of Asia Pacific.

List of Key Companies Profiled

• Abbott Laboratories
• Eli Lilly And Company
• Pfizer, Inc.
• Lupin Limited
• Astellas Pharma, Inc.
• Glenmark Pharmaceuticals Limited
• Boehringer Ingelheim International GmbH
• Novartis AG
• McKesson Corporation
• GlaxoSmithKline PLC (GSK)

Asia Pacific Diabetic Neuropathy Treatment Market Report Segmentation

By Distribution Channel

• Hospitals Pharmacies
• Retail Pharmacies
• Others

By Drug Class

• Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
• Antidepressants
• Opioid
• Capsaicin
• Others

By Disorder Type

• Peripheral Neuropathy
• Autonomic Neuropathy
• Proximal Neuropathy
• Focal Neuropathy

By Country

• China
• Japan
• India
• South Korea
• Australia
• Malaysia
• Rest of Asia Pacific

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Diabetic Neuropathy Treatment Market, by Distribution Channel
1.4.2 Asia Pacific Diabetic Neuropathy Treatment Market, by Drug Class
1.4.3 Asia Pacific Diabetic Neuropathy Treatment Market, by Disorder Type
1.4.4 Asia Pacific Diabetic Neuropathy Treatment Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. Asia Pacific Diabetic Neuropathy Treatment Market by Distribution Channel
4.1 Asia Pacific Hospitals Pharmacies Market by Country
4.2 Asia Pacific Retail Pharmacies Market by Country
4.3 Asia Pacific Others Market by Country

Chapter 5. Asia Pacific Diabetic Neuropathy Treatment Market by Drug Class
5.1 Asia Pacific Non-Steroidal Anti-inflammatory Drugs (NSAIDs) Market by Country
5.2 Asia Pacific Antidepressants Market by Country
5.3 Asia Pacific Opioid Market by Country
5.4 Asia Pacific Capsaicin Market by Country
5.5 Asia Pacific Others Market by Country

Chapter 6. Asia Pacific Diabetic Neuropathy Treatment Market by Disorder Type
6.1 Asia Pacific Peripheral Neuropathy Market by Country
6.2 Asia Pacific Autonomic Neuropathy Market by Country
6.3 Asia Pacific Proximal Neuropathy Market by Country
6.4 Asia Pacific Focal Neuropathy Market by Country

Chapter 7. Asia Pacific Diabetic Neuropathy Treatment Market by Country
7.1 China Diabetic Neuropathy Treatment Market
7.1.1 China Diabetic Neuropathy Treatment Market by Distribution Channel
7.1.2 China Diabetic Neuropathy Treatment Market by Drug Class
7.1.3 China Diabetic Neuropathy Treatment Market by Disorder Type
7.2 Japan Diabetic Neuropathy Treatment Market
7.2.1 Japan Diabetic Neuropathy Treatment Market by Distribution Channel
7.2.2 Japan Diabetic Neuropathy Treatment Market by Drug Class
7.2.3 Japan Diabetic Neuropathy Treatment Market by Disorder Type
7.3 India Diabetic Neuropathy Treatment Market
7.3.1 India Diabetic Neuropathy Treatment Market by Distribution Channel
7.3.2 India Diabetic Neuropathy Treatment Market by Drug Class
7.3.3 India Diabetic Neuropathy Treatment Market by Disorder Type
7.4 South Korea Diabetic Neuropathy Treatment Market
7.4.1 South Korea Diabetic Neuropathy Treatment Market by Distribution Channel
7.4.2 South Korea Diabetic Neuropathy Treatment Market by Drug Class
7.4.3 South Korea Diabetic Neuropathy Treatment Market by Disorder Type
7.5 Australia Diabetic Neuropathy Treatment Market
7.5.1 Australia Diabetic Neuropathy Treatment Market by Distribution Channel
7.5.2 Australia Diabetic Neuropathy Treatment Market by Drug Class
7.5.3 Australia Diabetic Neuropathy Treatment Market by Disorder Type
7.6 Malaysia Diabetic Neuropathy Treatment Market
7.6.1 Malaysia Diabetic Neuropathy Treatment Market by Distribution Channel
7.6.2 Malaysia Diabetic Neuropathy Treatment Market by Drug Class
7.6.3 Malaysia Diabetic Neuropathy Treatment Market by Disorder Type
7.7 Rest of Asia Pacific Diabetic Neuropathy Treatment Market
7.7.1 Rest of Asia Pacific Diabetic Neuropathy Treatment Market by Distribution Channel
7.7.2 Rest of Asia Pacific Diabetic Neuropathy Treatment Market by Drug Class
7.7.3 Rest of Asia Pacific Diabetic Neuropathy Treatment Market by Disorder Type

Chapter 8. Company Profiles
8.1 Abbott Laboratories
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Acquisition and Mergers:
8.1.5.2 Trial and Approval:
8.1.6 SWOT Analysis
8.2 Eli Lilly And Company
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Acquisition and Mergers:
8.2.6 SWOT Analysis
8.3 Pfizer, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional & Segmental Analysis
8.3.4 Research & Development Expense
8.3.5 SWOT Analysis
8.4 Lupin Limited
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.4.5 SWOT Analysis
8.5 Astellas Pharma, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expense
8.5.5 SWOT Analysis
8.6 Glenmark Pharmaceuticals Limited
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 SWOT Analysis
8.7 Boehringer Ingelheim International GmbH
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional & Segmental Analysis
8.7.4 Research & Development Expenses
8.7.5 SWOT Analysis
8.8 Novartis AG
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 Recent strategies and developments:
8.8.5.1 Acquisition and Mergers:
8.8.6 SWOT Analysis
8.9 McKesson Corporation
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental Analysis
8.9.4 Research & Development Expense
8.9.5 SWOT Analysis
8.10. GlaxoSmithKline PLC (GSK)
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expense
8.10.5 SWOT Analysis

TABLE 1 Asia Pacific Diabetic Neuropathy Treatment Market, 2020 - 2023, USD Million
TABLE 2 Asia Pacific Diabetic Neuropathy Treatment Market, 2024 - 2031, USD Million
TABLE 3 Asia Pacific Diabetic Neuropathy Treatment Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 4 Asia Pacific Diabetic Neuropathy Treatment Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 5 Asia Pacific Hospitals Pharmacies Market by Country, 2020 - 2023, USD Million
TABLE 6 Asia Pacific Hospitals Pharmacies Market by Country, 2024 - 2031, USD Million
TABLE 7 Asia Pacific Retail Pharmacies Market by Country, 2020 - 2023, USD Million
TABLE 8 Asia Pacific Retail Pharmacies Market by Country, 2024 - 2031, USD Million
TABLE 9 Asia Pacific Others Market by Country, 2020 - 2023, USD Million
TABLE 10 Asia Pacific Others Market by Country, 2024 - 2031, USD Million
TABLE 11 Asia Pacific Diabetic Neuropathy Treatment Market by Drug Class, 2020 - 2023, USD Million
TABLE 12 Asia Pacific Diabetic Neuropathy Treatment Market by Drug Class, 2024 - 2031, USD Million
TABLE 13 Asia Pacific Non-Steroidal Anti-inflammatory Drugs (NSAIDs) Market by Country, 2020 - 2023, USD Million
TABLE 14 Asia Pacific Non-Steroidal Anti-inflammatory Drugs (NSAIDs) Market by Country, 2024 - 2031, USD Million
TABLE 15 Asia Pacific Antidepressants Market by Country, 2020 - 2023, USD Million
TABLE 16 Asia Pacific Antidepressants Market by Country, 2024 - 2031, USD Million
TABLE 17 Asia Pacific Opioid Market by Country, 2020 - 2023, USD Million
TABLE 18 Asia Pacific Opioid Market by Country, 2024 - 2031, USD Million
TABLE 19 Asia Pacific Capsaicin Market by Country, 2020 - 2023, USD Million
TABLE 20 Asia Pacific Capsaicin Market by Country, 2024 - 2031, USD Million
TABLE 21 Asia Pacific Others Market by Country, 2020 - 2023, USD Million
TABLE 22 Asia Pacific Others Market by Country, 2024 - 2031, USD Million
TABLE 23 Asia Pacific Diabetic Neuropathy Treatment Market by Disorder Type, 2020 - 2023, USD Million
TABLE 24 Asia Pacific Diabetic Neuropathy Treatment Market by Disorder Type, 2024 - 2031, USD Million
TABLE 25 Asia Pacific Peripheral Neuropathy Market by Country, 2020 - 2023, USD Million
TABLE 26 Asia Pacific Peripheral Neuropathy Market by Country, 2024 - 2031, USD Million
TABLE 27 Asia Pacific Autonomic Neuropathy Market by Country, 2020 - 2023, USD Million
TABLE 28 Asia Pacific Autonomic Neuropathy Market by Country, 2024 - 2031, USD Million
TABLE 29 Asia Pacific Proximal Neuropathy Market by Country, 2020 - 2023, USD Million
TABLE 30 Asia Pacific Proximal Neuropathy Market by Country, 2024 - 2031, USD Million
TABLE 31 Asia Pacific Focal Neuropathy Market by Country, 2020 - 2023, USD Million
TABLE 32 Asia Pacific Focal Neuropathy Market by Country, 2024 - 2031, USD Million
TABLE 33 Asia Pacific Diabetic Neuropathy Treatment Market by Country, 2020 - 2023, USD Million
TABLE 34 Asia Pacific Diabetic Neuropathy Treatment Market by Country, 2024 - 2031, USD Million
TABLE 35 China Diabetic Neuropathy Treatment Market, 2020 - 2023, USD Million
TABLE 36 China Diabetic Neuropathy Treatment Market, 2024 - 2031, USD Million
TABLE 37 China Diabetic Neuropathy Treatment Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 38 China Diabetic Neuropathy Treatment Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 39 China Diabetic Neuropathy Treatment Market by Drug Class, 2020 - 2023, USD Million
TABLE 40 China Diabetic Neuropathy Treatment Market by Drug Class, 2024 - 2031, USD Million
TABLE 41 China Diabetic Neuropathy Treatment Market by Disorder Type, 2020 - 2023, USD Million
TABLE 42 China Diabetic Neuropathy Treatment Market by Disorder Type, 2024 - 2031, USD Million
TABLE 43 Japan Diabetic Neuropathy Treatment Market, 2020 - 2023, USD Million
TABLE 44 Japan Diabetic Neuropathy Treatment Market, 2024 - 2031, USD Million
TABLE 45 Japan Diabetic Neuropathy Treatment Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 46 Japan Diabetic Neuropathy Treatment Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 47 Japan Diabetic Neuropathy Treatment Market by Drug Class, 2020 - 2023, USD Million
TABLE 48 Japan Diabetic Neuropathy Treatment Market by Drug Class, 2024 - 2031, USD Million
TABLE 49 Japan Diabetic Neuropathy Treatment Market by Disorder Type, 2020 - 2023, USD Million
TABLE 50 Japan Diabetic Neuropathy Treatment Market by Disorder Type, 2024 - 2031, USD Million
TABLE 51 India Diabetic Neuropathy Treatment Market, 2020 - 2023, USD Million
TABLE 52 India Diabetic Neuropathy Treatment Market, 2024 - 2031, USD Million
TABLE 53 India Diabetic Neuropathy Treatment Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 54 India Diabetic Neuropathy Treatment Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 55 India Diabetic Neuropathy Treatment Market by Drug Class, 2020 - 2023, USD Million
TABLE 56 India Diabetic Neuropathy Treatment Market by Drug Class, 2024 - 2031, USD Million
TABLE 57 India Diabetic Neuropathy Treatment Market by Disorder Type, 2020 - 2023, USD Million
TABLE 58 India Diabetic Neuropathy Treatment Market by Disorder Type, 2024 - 2031, USD Million
TABLE 59 South Korea Diabetic Neuropathy Treatment Market, 2020 - 2023, USD Million
TABLE 60 South Korea Diabetic Neuropathy Treatment Market, 2024 - 2031, USD Million
TABLE 61 South Korea Diabetic Neuropathy Treatment Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 62 South Korea Diabetic Neuropathy Treatment Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 63 South Korea Diabetic Neuropathy Treatment Market by Drug Class, 2020 - 2023, USD Million
TABLE 64 South Korea Diabetic Neuropathy Treatment Market by Drug Class, 2024 - 2031, USD Million
TABLE 65 South Korea Diabetic Neuropathy Treatment Market by Disorder Type, 2020 - 2023, USD Million
TABLE 66 South Korea Diabetic Neuropathy Treatment Market by Disorder Type, 2024 - 2031, USD Million
TABLE 67 Australia Diabetic Neuropathy Treatment Market, 2020 - 2023, USD Million
TABLE 68 Australia Diabetic Neuropathy Treatment Market, 2024 - 2031, USD Million
TABLE 69 Australia Diabetic Neuropathy Treatment Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 70 Australia Diabetic Neuropathy Treatment Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 71 Australia Diabetic Neuropathy Treatment Market by Drug Class, 2020 - 2023, USD Million
TABLE 72 Australia Diabetic Neuropathy Treatment Market by Drug Class, 2024 - 2031, USD Million
TABLE 73 Australia Diabetic Neuropathy Treatment Market by Disorder Type, 2020 - 2023, USD Million
TABLE 74 Australia Diabetic Neuropathy Treatment Market by Disorder Type, 2024 - 2031, USD Million
TABLE 75 Malaysia Diabetic Neuropathy Treatment Market, 2020 - 2023, USD Million
TABLE 76 Malaysia Diabetic Neuropathy Treatment Market, 2024 - 2031, USD Million
TABLE 77 Malaysia Diabetic Neuropathy Treatment Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 78 Malaysia Diabetic Neuropathy Treatment Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 79 Malaysia Diabetic Neuropathy Treatment Market by Drug Class, 2020 - 2023, USD Million
TABLE 80 Malaysia Diabetic Neuropathy Treatment Market by Drug Class, 2024 - 2031, USD Million
TABLE 81 Malaysia Diabetic Neuropathy Treatment Market by Disorder Type, 2020 - 2023, USD Million
TABLE 82 Malaysia Diabetic Neuropathy Treatment Market by Disorder Type, 2024 - 2031, USD Million
TABLE 83 Rest of Asia Pacific Diabetic Neuropathy Treatment Market, 2020 - 2023, USD Million
TABLE 84 Rest of Asia Pacific Diabetic Neuropathy Treatment Market, 2024 - 2031, USD Million
TABLE 85 Rest of Asia Pacific Diabetic Neuropathy Treatment Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 86 Rest of Asia Pacific Diabetic Neuropathy Treatment Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 87 Rest of Asia Pacific Diabetic Neuropathy Treatment Market by Drug Class, 2020 - 2023, USD Million
TABLE 88 Rest of Asia Pacific Diabetic Neuropathy Treatment Market by Drug Class, 2024 - 2031, USD Million
TABLE 89 Rest of Asia Pacific Diabetic Neuropathy Treatment Market by Disorder Type, 2020 - 2023, USD Million
TABLE 90 Rest of Asia Pacific Diabetic Neuropathy Treatment Market by Disorder Type, 2024 - 2031, USD Million
TABLE 91 Key Information – Abbott Laboratories
TABLE 92 Key Information – Eli Lilly And Company
TABLE 93 Key Information – Pfizer, Inc.
TABLE 94 Key Information – Lupin Limited
TABLE 95 key information – Astellas Pharma, Inc.
TABLE 96 Key Information – Glenmark Pharmaceuticals Limited
TABLE 97 Key Information – Boehringer Ingelheim International GmbH
TABLE 98 Key Information – Novartis AG
TABLE 99 Key Information – McKesson Corporation
TABLE 100 Key Information – GlaxoSmithKline PLC

List of Figures
FIG 1 Methodology for the research
FIG 2 Asia Pacific Diabetic Neuropathy Treatment Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting Diabetic Neuropathy Treatment Market
FIG 4 Porter’s Five Forces Analysis – Diabetic Neuropathy Treatment Market
FIG 5 Asia Pacific Diabetic Neuropathy Treatment Market share by Distribution Channel, 2023
FIG 6 Asia Pacific Diabetic Neuropathy Treatment Market share by Distribution Channel, 2031
FIG 7 Asia Pacific Diabetic Neuropathy Treatment Market by Distribution Channel, 2020 - 2031, USD Million
FIG 8 Asia Pacific Diabetic Neuropathy Treatment Market share by Drug Class, 2023
FIG 9 Asia Pacific Diabetic Neuropathy Treatment Market share by Drug Class, 2031
FIG 10 Asia Pacific Diabetic Neuropathy Treatment Market by Drug Class, 2020 - 2031, USD Million
FIG 11 Asia Pacific Diabetic Neuropathy Treatment Market share by Disorder Type, 2023
FIG 12 Asia Pacific Diabetic Neuropathy Treatment Market share by Disorder Type, 2031
FIG 13 Asia Pacific Diabetic Neuropathy Treatment Market by Disorder Type, 2020 - 2031, USD Million
FIG 14 Asia Pacific Diabetic Neuropathy Treatment Market share by Country, 2023
FIG 15 Asia Pacific Diabetic Neuropathy Treatment Market share by Country, 2031
FIG 16 Asia Pacific Diabetic Neuropathy Treatment Market by Country, 2020 - 2031, USD Million
FIG 17 Recent strategies and developments: Abbott Laboratories
FIG 18 SWOT Analysis: Abbott Laboratories
FIG 19 Swot Analysis: Eli Lilly And Company
FIG 20 SWOT Analysis: Pfizer, Inc.
FIG 21 SWOT Analysis: Lupin Limited
FIG 22 SWOT Analysis: Astellas Pharma, Inc.
FIG 23 SWOT Analysis: Glenmark Pharmaceuticals Limited
FIG 24 SWOT Analysis: Boehringer Ingelheim International GmbH
FIG 25 SWOT Analysis: Novartis AG
FIG 26 SWOT Analysis: McKesson Corporation
FIG 27 SWOT Analysis: GlaxoSmithKline PLC